HEADER SIGNALING PROTEIN 17-AUG-07 2R09 TITLE CRYSTAL STRUCTURE OF AUTOINHIBITED FORM OF GRP1 ARF GTPASE EXCHANGE TITLE 2 FACTOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: CYTOHESIN-3; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: SEC7 DOMAIN 2 (RESIDUES 63-399); COMPND 5 SYNONYM: PH, SEC7 AND COILED-COIL DOMAIN-CONTAINING PROTEIN 3, CLM3, COMPND 6 SEC7 HOMOLOG C, MSEC7-3, ARF NUCLEOTIDE-BINDING SITE OPENER 3, COMPND 7 PROTEIN ARNO3, GENERAL RECEPTOR OF PHOSPHOINOSITIDES 1, GRP1; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: HOUSE MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 GENE: PSCD3, GRP1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)RIL; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET15B KEYWDS AUTOINHIBITION, GRP1, PIP3, ARF, 3-PHOSPHOINOSITIDE, PLECKSTRIN KEYWDS 2 HOMOLOGY DOMAIN, GUANINE-NUCLEOTIDE RELEASING FACTOR, SIGNALING KEYWDS 3 PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR J.P.DINITTO,A.DELPRATO,M.T.GABE LEE,T.C.CRONIN,S.HUANG,A.GUILHERME, AUTHOR 2 M.P.CZECH,D.G.LAMBRIGHT REVDAT 5 30-OCT-24 2R09 1 REMARK REVDAT 4 20-OCT-21 2R09 1 REMARK SEQADV HETSYN LINK REVDAT 3 13-JUL-11 2R09 1 VERSN REVDAT 2 24-FEB-09 2R09 1 VERSN REVDAT 1 04-DEC-07 2R09 0 JRNL AUTH J.P.DINITTO,A.DELPRATO,M.T.GABE LEE,T.C.CRONIN,S.HUANG, JRNL AUTH 2 A.GUILHERME,M.P.CZECH,D.G.LAMBRIGHT JRNL TITL STRUCTURAL BASIS AND MECHANISM OF AUTOREGULATION IN JRNL TITL 2 3-PHOSPHOINOSITIDE-DEPENDENT GRP1 FAMILY ARF GTPASE EXCHANGE JRNL TITL 3 FACTORS. JRNL REF MOL.CELL V. 28 569 2007 JRNL REFN ISSN 1097-2765 JRNL PMID 18042453 JRNL DOI 10.1016/J.MOLCEL.2007.09.017 REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0005 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 68704 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.206 REMARK 3 R VALUE (WORKING SET) : 0.204 REMARK 3 FREE R VALUE : 0.241 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 3652 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.90 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.95 REMARK 3 REFLECTION IN BIN (WORKING SET) : 4969 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 BIN R VALUE (WORKING SET) : 0.2200 REMARK 3 BIN FREE R VALUE SET COUNT : 267 REMARK 3 BIN FREE R VALUE : 0.2490 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5603 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 128 REMARK 3 SOLVENT ATOMS : 807 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 33.48 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.91000 REMARK 3 B22 (A**2) : -1.53000 REMARK 3 B33 (A**2) : -0.38000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.155 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.144 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.093 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 3.055 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.949 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.932 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 5858 ; 0.008 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 7913 ; 1.074 ; 1.973 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 682 ; 4.995 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 304 ;33.141 ;23.750 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1022 ;12.414 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 48 ;17.201 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 819 ; 0.073 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4442 ; 0.004 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 2719 ; 0.182 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 4009 ; 0.300 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 784 ; 0.128 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 125 ; 0.163 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 86 ; 0.145 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3526 ; 0.819 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 5512 ; 1.100 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2630 ; 1.633 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 2401 ; 2.468 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 2R09 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 07-SEP-07. REMARK 100 THE DEPOSITION ID IS D_1000044264. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 25-SEP-04 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X25 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9791, 0.97872, 1.1627 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 72844 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.950 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 6.000 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: MAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: SHARP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 56.20 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.81 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 10-15% PEG 6000, 50 MM TRIS, PH 8.0, REMARK 280 0.2 M LI2SO4, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 41.79950 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 57.65400 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 47.30550 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 57.65400 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 41.79950 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 47.30550 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MSE A 53 REMARK 465 ASN A 397 REMARK 465 LYS A 398 REMARK 465 LYS A 399 REMARK 465 MSE B 53 REMARK 465 ILE B 395 REMARK 465 ALA B 396 REMARK 465 ASN B 397 REMARK 465 LYS B 398 REMARK 465 LYS B 399 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 381 158.93 68.74 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 400 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 403 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 404 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 4IP A 405 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PGE A 406 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PE5 A 407 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 4IP B 400 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2R0D RELATED DB: PDB DBREF 2R09 A 63 399 UNP O08967 CYH3_MOUSE 63 399 DBREF 2R09 B 63 399 UNP O08967 CYH3_MOUSE 63 399 SEQADV 2R09 MSE A 53 UNP O08967 EXPRESSION TAG SEQADV 2R09 GLY A 54 UNP O08967 EXPRESSION TAG SEQADV 2R09 HIS A 55 UNP O08967 EXPRESSION TAG SEQADV 2R09 HIS A 56 UNP O08967 EXPRESSION TAG SEQADV 2R09 HIS A 57 UNP O08967 EXPRESSION TAG SEQADV 2R09 HIS A 58 UNP O08967 EXPRESSION TAG SEQADV 2R09 HIS A 59 UNP O08967 EXPRESSION TAG SEQADV 2R09 HIS A 60 UNP O08967 EXPRESSION TAG SEQADV 2R09 GLY A 61 UNP O08967 EXPRESSION TAG SEQADV 2R09 SER A 62 UNP O08967 EXPRESSION TAG SEQADV 2R09 ALA A 68 UNP O08967 LYS 68 ENGINEERED MUTATION SEQADV 2R09 TYR A 260 UNP O08967 HIS 260 ENGINEERED MUTATION SEQADV 2R09 MSE B 53 UNP O08967 EXPRESSION TAG SEQADV 2R09 GLY B 54 UNP O08967 EXPRESSION TAG SEQADV 2R09 HIS B 55 UNP O08967 EXPRESSION TAG SEQADV 2R09 HIS B 56 UNP O08967 EXPRESSION TAG SEQADV 2R09 HIS B 57 UNP O08967 EXPRESSION TAG SEQADV 2R09 HIS B 58 UNP O08967 EXPRESSION TAG SEQADV 2R09 HIS B 59 UNP O08967 EXPRESSION TAG SEQADV 2R09 HIS B 60 UNP O08967 EXPRESSION TAG SEQADV 2R09 GLY B 61 UNP O08967 EXPRESSION TAG SEQADV 2R09 SER B 62 UNP O08967 EXPRESSION TAG SEQADV 2R09 ALA B 68 UNP O08967 LYS 68 ENGINEERED MUTATION SEQADV 2R09 TYR B 260 UNP O08967 HIS 260 ENGINEERED MUTATION SEQRES 1 A 347 MSE GLY HIS HIS HIS HIS HIS HIS GLY SER THR THR GLN SEQRES 2 A 347 ARG ASN ALA GLN ILE ALA MSE GLY ARG LYS LYS PHE ASN SEQRES 3 A 347 MSE ASP PRO LYS LYS GLY ILE GLN PHE LEU ILE GLU ASN SEQRES 4 A 347 ASP LEU LEU GLN SER SER PRO GLU ASP VAL ALA GLN PHE SEQRES 5 A 347 LEU TYR LYS GLY GLU GLY LEU ASN LYS THR VAL ILE GLY SEQRES 6 A 347 ASP TYR LEU GLY GLU ARG ASP ASP PHE ASN ILE LYS VAL SEQRES 7 A 347 LEU GLN ALA PHE VAL GLU LEU HIS GLU PHE ALA ASP LEU SEQRES 8 A 347 ASN LEU VAL GLN ALA LEU ARG GLN PHE LEU TRP SER PHE SEQRES 9 A 347 ARG LEU PRO GLY GLU ALA GLN LYS ILE ASP ARG MSE MSE SEQRES 10 A 347 GLU ALA PHE ALA SER ARG TYR CYS LEU CYS ASN PRO GLY SEQRES 11 A 347 VAL PHE GLN SER THR ASP THR CYS TYR VAL LEU SER PHE SEQRES 12 A 347 ALA ILE ILE MSE LEU ASN THR SER LEU HIS ASN HIS ASN SEQRES 13 A 347 VAL ARG ASP LYS PRO THR ALA GLU ARG PHE ILE THR MSE SEQRES 14 A 347 ASN ARG GLY ILE ASN GLU GLY GLY ASP LEU PRO GLU GLU SEQRES 15 A 347 LEU LEU ARG ASN LEU TYR GLU SER ILE LYS ASN GLU PRO SEQRES 16 A 347 PHE LYS ILE PRO GLU ASP ASP GLY ASN ASP LEU THR TYR SEQRES 17 A 347 THR PHE PHE ASN PRO ASP ARG GLU GLY TRP LEU LEU LYS SEQRES 18 A 347 LEU GLY GLY ARG VAL LYS THR TRP LYS ARG ARG TRP PHE SEQRES 19 A 347 ILE LEU THR ASP ASN CYS LEU TYR TYR PHE GLU TYR THR SEQRES 20 A 347 THR ASP LYS GLU PRO ARG GLY ILE ILE PRO LEU GLU ASN SEQRES 21 A 347 LEU SER ILE ARG GLU VAL GLU ASP PRO ARG LYS PRO ASN SEQRES 22 A 347 CYS PHE GLU LEU TYR ASN PRO SER HIS LYS GLY GLN VAL SEQRES 23 A 347 ILE LYS ALA CYS LYS THR GLU ALA ASP GLY ARG VAL VAL SEQRES 24 A 347 GLU GLY ASN HIS VAL VAL TYR ARG ILE SER ALA PRO SER SEQRES 25 A 347 PRO GLU GLU LYS GLU GLU TRP MSE LYS SER ILE LYS ALA SEQRES 26 A 347 SER ILE SER ARG ASP PRO PHE TYR ASP MSE LEU ALA THR SEQRES 27 A 347 ARG LYS ARG ARG ILE ALA ASN LYS LYS SEQRES 1 B 347 MSE GLY HIS HIS HIS HIS HIS HIS GLY SER THR THR GLN SEQRES 2 B 347 ARG ASN ALA GLN ILE ALA MSE GLY ARG LYS LYS PHE ASN SEQRES 3 B 347 MSE ASP PRO LYS LYS GLY ILE GLN PHE LEU ILE GLU ASN SEQRES 4 B 347 ASP LEU LEU GLN SER SER PRO GLU ASP VAL ALA GLN PHE SEQRES 5 B 347 LEU TYR LYS GLY GLU GLY LEU ASN LYS THR VAL ILE GLY SEQRES 6 B 347 ASP TYR LEU GLY GLU ARG ASP ASP PHE ASN ILE LYS VAL SEQRES 7 B 347 LEU GLN ALA PHE VAL GLU LEU HIS GLU PHE ALA ASP LEU SEQRES 8 B 347 ASN LEU VAL GLN ALA LEU ARG GLN PHE LEU TRP SER PHE SEQRES 9 B 347 ARG LEU PRO GLY GLU ALA GLN LYS ILE ASP ARG MSE MSE SEQRES 10 B 347 GLU ALA PHE ALA SER ARG TYR CYS LEU CYS ASN PRO GLY SEQRES 11 B 347 VAL PHE GLN SER THR ASP THR CYS TYR VAL LEU SER PHE SEQRES 12 B 347 ALA ILE ILE MSE LEU ASN THR SER LEU HIS ASN HIS ASN SEQRES 13 B 347 VAL ARG ASP LYS PRO THR ALA GLU ARG PHE ILE THR MSE SEQRES 14 B 347 ASN ARG GLY ILE ASN GLU GLY GLY ASP LEU PRO GLU GLU SEQRES 15 B 347 LEU LEU ARG ASN LEU TYR GLU SER ILE LYS ASN GLU PRO SEQRES 16 B 347 PHE LYS ILE PRO GLU ASP ASP GLY ASN ASP LEU THR TYR SEQRES 17 B 347 THR PHE PHE ASN PRO ASP ARG GLU GLY TRP LEU LEU LYS SEQRES 18 B 347 LEU GLY GLY ARG VAL LYS THR TRP LYS ARG ARG TRP PHE SEQRES 19 B 347 ILE LEU THR ASP ASN CYS LEU TYR TYR PHE GLU TYR THR SEQRES 20 B 347 THR ASP LYS GLU PRO ARG GLY ILE ILE PRO LEU GLU ASN SEQRES 21 B 347 LEU SER ILE ARG GLU VAL GLU ASP PRO ARG LYS PRO ASN SEQRES 22 B 347 CYS PHE GLU LEU TYR ASN PRO SER HIS LYS GLY GLN VAL SEQRES 23 B 347 ILE LYS ALA CYS LYS THR GLU ALA ASP GLY ARG VAL VAL SEQRES 24 B 347 GLU GLY ASN HIS VAL VAL TYR ARG ILE SER ALA PRO SER SEQRES 25 B 347 PRO GLU GLU LYS GLU GLU TRP MSE LYS SER ILE LYS ALA SEQRES 26 B 347 SER ILE SER ARG ASP PRO PHE TYR ASP MSE LEU ALA THR SEQRES 27 B 347 ARG LYS ARG ARG ILE ALA ASN LYS LYS MODRES 2R09 MSE A 72 MET SELENOMETHIONINE MODRES 2R09 MSE A 79 MET SELENOMETHIONINE MODRES 2R09 MSE A 168 MET SELENOMETHIONINE MODRES 2R09 MSE A 169 MET SELENOMETHIONINE MODRES 2R09 MSE A 199 MET SELENOMETHIONINE MODRES 2R09 MSE A 221 MET SELENOMETHIONINE MODRES 2R09 MSE A 372 MET SELENOMETHIONINE MODRES 2R09 MSE A 387 MET SELENOMETHIONINE MODRES 2R09 MSE B 72 MET SELENOMETHIONINE MODRES 2R09 MSE B 79 MET SELENOMETHIONINE MODRES 2R09 MSE B 168 MET SELENOMETHIONINE MODRES 2R09 MSE B 169 MET SELENOMETHIONINE MODRES 2R09 MSE B 199 MET SELENOMETHIONINE MODRES 2R09 MSE B 221 MET SELENOMETHIONINE MODRES 2R09 MSE B 372 MET SELENOMETHIONINE MODRES 2R09 MSE B 387 MET SELENOMETHIONINE HET MSE A 72 8 HET MSE A 79 8 HET MSE A 168 8 HET MSE A 169 8 HET MSE A 199 8 HET MSE A 221 8 HET MSE A 372 8 HET MSE A 387 8 HET MSE B 72 8 HET MSE B 79 8 HET MSE B 168 8 HET MSE B 169 8 HET MSE B 199 8 HET MSE B 221 8 HET MSE B 372 8 HET MSE B 387 8 HET SO4 A 1 5 HET SO4 A 400 5 HET SO4 A 401 5 HET SO4 A 402 5 HET SO4 A 403 5 HET SO4 A 404 5 HET 4IP A 405 28 HET PGE A 406 10 HET PE5 A 407 27 HET SO4 B 1 5 HET 4IP B 400 28 HETNAM MSE SELENOMETHIONINE HETNAM SO4 SULFATE ION HETNAM 4IP INOSITOL-(1,3,4,5)-TETRAKISPHOSPHATE HETNAM PGE TRIETHYLENE GLYCOL HETNAM PE5 3,6,9,12,15,18,21,24-OCTAOXAHEXACOSAN-1-OL HETSYN PE5 2-(2-{2-[2-(2-{2-[2-(2-ETHOXY-ETHOXY)-ETHOXY]-ETHOXY}- HETSYN 2 PE5 ETHOXY)-ETHOXY]-ETHOXY}-ETHOXY)-ETHANOL; POLYETHYLENE HETSYN 3 PE5 GLYCOL PEG400 FORMUL 1 MSE 16(C5 H11 N O2 SE) FORMUL 3 SO4 7(O4 S 2-) FORMUL 9 4IP 2(C6 H16 O18 P4) FORMUL 10 PGE C6 H14 O4 FORMUL 11 PE5 C18 H38 O9 FORMUL 14 HOH *807(H2 O) HELIX 1 1 THR A 63 ASP A 80 1 18 HELIX 2 2 ASP A 80 ASN A 91 1 12 HELIX 3 3 SER A 97 GLY A 108 1 12 HELIX 4 4 ASN A 112 GLU A 122 1 11 HELIX 5 5 ASP A 124 LEU A 137 1 14 HELIX 6 6 ASN A 144 LEU A 153 1 10 HELIX 7 7 GLU A 161 ASN A 180 1 20 HELIX 8 8 SER A 186 ASN A 206 1 21 HELIX 9 9 THR A 214 ASN A 222 1 9 HELIX 10 10 PRO A 232 GLU A 246 1 15 HELIX 11 11 ASP A 257 THR A 261 5 5 HELIX 12 12 SER A 364 ARG A 381 1 18 HELIX 13 13 ASP A 382 ALA A 396 1 15 HELIX 14 14 HIS B 60 ASP B 80 1 21 HELIX 15 15 ASP B 80 ASN B 91 1 12 HELIX 16 16 SER B 97 GLY B 108 1 12 HELIX 17 17 ASN B 112 GLY B 121 1 10 HELIX 18 18 ASP B 124 LEU B 137 1 14 HELIX 19 19 ASN B 144 LEU B 153 1 10 HELIX 20 20 GLU B 161 ASN B 180 1 20 HELIX 21 21 SER B 186 ASN B 206 1 21 HELIX 22 22 THR B 214 ASN B 222 1 9 HELIX 23 23 PRO B 232 GLU B 246 1 15 HELIX 24 24 ASP B 257 THR B 261 5 5 HELIX 25 25 SER B 364 ARG B 381 1 18 HELIX 26 26 ARG B 381 ARG B 394 1 14 SHEET 1 A 9 SER A 314 VAL A 318 0 SHEET 2 A 9 CYS A 326 TYR A 330 -1 O GLU A 328 N ARG A 316 SHEET 3 A 9 TYR A 358 SER A 361 -1 O ILE A 360 N PHE A 327 SHEET 4 A 9 ARG A 267 LEU A 274 -1 N LEU A 272 O SER A 361 SHEET 5 A 9 TRP A 281 THR A 289 -1 O PHE A 286 N GLY A 269 SHEET 6 A 9 CYS A 292 PHE A 296 -1 O TYR A 294 N ILE A 287 SHEET 7 A 9 GLY A 306 PRO A 309 -1 O ILE A 308 N LEU A 293 SHEET 8 A 9 CYS A 342 THR A 344 -1 O CYS A 342 N ILE A 307 SHEET 9 A 9 VAL A 350 GLU A 352 -1 O VAL A 351 N LYS A 343 SHEET 1 B 9 SER B 314 VAL B 318 0 SHEET 2 B 9 CYS B 326 TYR B 330 -1 O GLU B 328 N ARG B 316 SHEET 3 B 9 TYR B 358 SER B 361 -1 O ILE B 360 N PHE B 327 SHEET 4 B 9 ARG B 267 LEU B 274 -1 N LEU B 272 O SER B 361 SHEET 5 B 9 TRP B 281 THR B 289 -1 O LEU B 288 N ARG B 267 SHEET 6 B 9 CYS B 292 PHE B 296 -1 O TYR B 294 N ILE B 287 SHEET 7 B 9 GLY B 306 PRO B 309 -1 O ILE B 308 N LEU B 293 SHEET 8 B 9 CYS B 342 THR B 344 -1 O CYS B 342 N ILE B 307 SHEET 9 B 9 VAL B 350 GLU B 352 -1 O VAL B 351 N LYS B 343 LINK C ALA A 71 N MSE A 72 1555 1555 1.34 LINK C MSE A 72 N GLY A 73 1555 1555 1.33 LINK C ASN A 78 N MSE A 79 1555 1555 1.33 LINK C MSE A 79 N ASP A 80 1555 1555 1.33 LINK C ARG A 167 N MSE A 168 1555 1555 1.33 LINK C MSE A 168 N MSE A 169 1555 1555 1.33 LINK C MSE A 169 N GLU A 170 1555 1555 1.33 LINK C ILE A 198 N MSE A 199 1555 1555 1.34 LINK C MSE A 199 N LEU A 200 1555 1555 1.34 LINK C THR A 220 N MSE A 221 1555 1555 1.34 LINK C MSE A 221 N ASN A 222 1555 1555 1.33 LINK C TRP A 371 N MSE A 372 1555 1555 1.33 LINK C MSE A 372 N LYS A 373 1555 1555 1.33 LINK C ASP A 386 N MSE A 387 1555 1555 1.33 LINK C MSE A 387 N LEU A 388 1555 1555 1.33 LINK C ALA B 71 N MSE B 72 1555 1555 1.33 LINK C MSE B 72 N GLY B 73 1555 1555 1.33 LINK C ASN B 78 N MSE B 79 1555 1555 1.33 LINK C MSE B 79 N ASP B 80 1555 1555 1.33 LINK C ARG B 167 N MSE B 168 1555 1555 1.33 LINK C MSE B 168 N MSE B 169 1555 1555 1.33 LINK C MSE B 169 N GLU B 170 1555 1555 1.33 LINK C ILE B 198 N MSE B 199 1555 1555 1.33 LINK C MSE B 199 N LEU B 200 1555 1555 1.33 LINK C THR B 220 N MSE B 221 1555 1555 1.33 LINK C MSE B 221 N ASN B 222 1555 1555 1.33 LINK C TRP B 371 N MSE B 372 1555 1555 1.33 LINK C MSE B 372 N LYS B 373 1555 1555 1.34 LINK C ASP B 386 N MSE B 387 1555 1555 1.34 LINK C MSE B 387 N LEU B 388 1555 1555 1.33 SITE 1 AC1 7 HIS A 57 HIS A 58 HIS A 60 HOH A 695 SITE 2 AC1 7 LEU B 272 LYS B 323 PRO B 324 SITE 1 AC2 7 GLN A 147 ARG A 150 SER A 242 GLN A 337 SITE 2 AC2 7 HOH A 448 HOH A 498 HOH A 534 SITE 1 AC3 9 ARG A 210 HOH A 440 HOH A 517 HOH A 741 SITE 2 AC3 9 HOH A 760 HOH A 799 HIS B 55 HIS B 56 SITE 3 AC3 9 HIS B 57 SITE 1 AC4 5 ARG A 217 HOH A 557 HOH A 599 HOH A 788 SITE 2 AC4 5 HIS B 60 SITE 1 AC5 3 LYS A 282 ARG A 284 HOH A 693 SITE 1 AC6 5 ASP A 301 LYS A 302 GLU A 303 HOH A 569 SITE 2 AC6 5 HOH A 774 SITE 1 AC7 6 TRP A 270 PRO A 363 GLY B 54 HOH B 535 SITE 2 AC7 6 HOH B 578 HOH B 616 SITE 1 AC8 24 LYS A 273 GLY A 275 GLY A 276 ARG A 277 SITE 2 AC8 24 VAL A 278 THR A 280 LYS A 282 ARG A 284 SITE 3 AC8 24 TYR A 295 ARG A 305 LYS A 343 ASN A 354 SITE 4 AC8 24 HIS A 355 HOH A 409 HOH A 415 HOH A 418 SITE 5 AC8 24 HOH A 430 HOH A 432 HOH A 442 HOH A 450 SITE 6 AC8 24 HOH A 513 HOH A 556 HOH A 651 HOH A 744 SITE 1 AC9 3 ASN A 208 PHE A 263 HOH A 684 SITE 1 BC1 12 ALA A 196 MSE A 221 ASN A 222 ARG A 223 SITE 2 BC1 12 THR A 289 ASP A 290 TYR A 385 LEU A 388 SITE 3 BC1 12 ALA A 389 LYS A 392 SER B 62 GLN B 65 SITE 1 BC2 23 LYS B 107 LYS B 273 GLY B 275 GLY B 276 SITE 2 BC2 23 ARG B 277 VAL B 278 THR B 280 LYS B 282 SITE 3 BC2 23 ARG B 284 TYR B 295 ARG B 305 LYS B 343 SITE 4 BC2 23 ASN B 354 HIS B 355 HOH B 404 HOH B 416 SITE 5 BC2 23 HOH B 417 HOH B 431 HOH B 433 HOH B 495 SITE 6 BC2 23 HOH B 621 HOH B 639 HOH B 645 CRYST1 83.599 94.611 115.308 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011962 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010570 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008672 0.00000